#Cabozantib #caboxib #xl184 #cabozantinib80mg #cometriq #cabozanix #HepatocellularCarcinoma (HCC) #hyroidcancer (DTC) #RenalCellCarcinoma (RCC) #TargetedTherapy
WeChat : drug-international / lifesaving-medicine website : medicine-international.com
HOPE for the Week: The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.
#HOPEForTheWeek #HepatocellularCarcinoma
onlinelibrary.wiley.com/doi/10.1111/ao…
#AdvancedGlycationEndproduct (AGE)⏫liver matrix #Viscoelasticity (Collagen bundle network with shorter fibers & smaller angles), but not #Stiffness
#T2DM #NASH #MASH
A mechanosensitive integrin β1–Tensin 1– #YAP cascade (⏫by high Viscoelasticity) ⏫ #HepatoCellularCarcinoma …
Today we announced promising preliminary data from our landmark first-in-human MYCHELANGELO™ I study evaluating our lead #EpigenomicController for #HepatocellularCarcinoma . Read our press release for more including webcast access: brnw.ch/21wCWsW $OMGA
Lentiviral or Alb-Cre overexpression of #FGF9 ->
⏫Wnt signal
⏫ #NASH -associated #HepatoCellularCarcinoma
via⏫ERK1/2 to⏬GSK3β-ubiquitin degradation of βCatenin
Direct proliferative & fibrotic effects of FGF9 on hepatoma cells
#AdvSci 2023 Advanced Sci News
onlinelibrary.wiley.com/doi/10.1002/ad…
Ablation of left lobe heptocellular carcinoma HCC with good results UT Houston_IR
#InterventionalRadiology #InterventionalOncology #minimallyinvasiveprocedures #IAmIR #HepatocellularCarcinoma #HVC #Cancer #Therapy #Management #GlobalEducation #ablation #LocalRegionalTherapy
Just published!💻
#Ficolin 3 promotes #ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis
Read here👇
jeccr.biomedcentral.com/articles/10.11…
#Hepatocellularcarcinoma
That was indeed a wonderful talk by Rhea Pai at Telethon Kids Institute about her PhD work! Thanks for letting us know more about oncofetal reprogramming of tumor ecosystem!!
#hepatocellularcarcinoma #oncofetal #reprogramming
🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in #hepatocellularcarcinoma #ASCO23
👉Interesting signal of activity for anti-TIGIT 💊in #HCC (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
ESMO - Eur. Oncology OncoAlert EASL Education EASL Education…
Arginine is a second messenger-like molecule that reprograms metabolism to promote tumor growth. Cell #Phenomics #HepatocellularCarcinoma #metabolism cell.com/cell/fulltext/…
Happy to announce I'll be presenting our work on the changing treatment patterns for #HepatocellularCarcinoma at the upcoming ASCO Medical Student & Resident Abstract Forum. Thank you Dana-Farber Division of Population Sciences and Chris Manz for the support on this important topic. #LiverTwitter #GItwitter
May Issue: Outcomes of #SalvageSurgery Versus Non-Salvage Surgery for Initially Unresectable #HepatocellularCarcinoma After Conversion Therapy with Transcatheter Arterial #Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody
rdcu.be/dHcVc
Julie Hallet
Scientists from the Terasaki Institute have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer.
buff.ly/48aNeVE
#TerasakiInstitute #HepatoCellularCarcinoma
American Liver Foundation's Corporate Council Meeting September 12th, 2023! Ali Zarrinpar American Liver Foundation National #liverhealth #liverdisease #livertumor #livertransplant #hcv #hepc #hepatocellularcarcinoma #hepatitis #cirrhosis
🎙️SBRT showed ⬆️local antitumoral activity for #HCC than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ OncoAlert IJROBP - The Red Journal
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for #hepatocellularcarcinoma (HCC)
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB…
Thank you ESMO - Eur. Oncology for the invitation as Faculty in the just concluded ESMO Preceptorship on Liver Cancer – the first ESMO educational course held in Kenya!
It was such a pleasure and a great learning experience! #Quality #standardofcare #livercancer #hepatocellularcarcinoma
🔥Pembrolizumab vs plc as 2nd Line in #HepatocellularCarcinoma
Journal of Clinical Oncology
doi.org/10.1200/JCO.22…
✅Asian phs-III KEYNOTE-394
👉ORR: 12.7 vs 1.3%
👉mPFS: 2.6 vs 2.3 mo
👉moS: 14.6 vs 13.0 mo
🧐In line with KN-224& 240-> efficacy in a subgroup
ESMO - Eur. Oncology EASL Education #livertwitter
